Maintain PG at or below benchmark weight with stop at $142; avoid adding at $147-148 due to full valuation and 8% FY27 EPS headwind
Hold rating is appropriate as all three risk analysts (Aggressive, Conservative, Neutral) converge on Hold—their independent convergence signals roughly symmetric asymmetry. The Aggressive Analyst's franchise quality case (30.3% ROE, 70-year dividend streak, $15.15B FCF, 1.48x dividend coverage, 0.377 beta, A+ credit) is valid but their $146 starter entry violates entry discipline. The Neutral Analyst correctly rejects this while recognizing technical support at 200 SMA ($145.81) and positive MACD histogram (+$0.34). The Conservative Analyst's valuation concerns (19.95x forward P/E, 3.74 PEG, 2.98% yield 150bps below 4.5% Treasury, quarterly EPS deceleration from Q1 $1.95 to Q4 $1.26, management's own 8% FY27 core EPS headwind) justify avoiding additions at current levels. The 200 SMA defense and higher lows since August 20 ($142.97 → $143.14 → $145.12 → $146.21 → $147.64) prevent premature underweight. Prior Underweight calls (08/26-08/31) generated +0.7% to +1.9% alpha from Treasury redeployment, not equity avoidance, so that leg has already been harvested—no fresh yield alpha remains from additional trimming. Core-position stop corrected to $142 per Neutral Analyst resolution of trader's mechanically broken entry-$140/stop-$144 error. Price target $149.0 reflects ~2% upside from $147.64.
| Position | Action |
|---|---|
| Core position (existing) | Stop at $142 (2x ATR below current price, lower Bollinger band, August 20 swing low zone) |
| New add at $140 | Stop below $138 (below 52-week low at $137.62) to absorb volatility into October catalyst |
| Close below $142 on volume ≥ 20-day average | Initial 25% trim |
| Close below $138 | Full Underweight escalation (hard stop) |
| Close above $152 on volume >10M shares | Bullish breakout trigger confirmed; validate MACD crossover |
| Wick above $152 but close back inside range | SELL signal, not confirmation |
PG is a buyable weakness into a defensive rotation tailwind, offering elite 30%+ ROE, 70 years of consecutive dividend growth, and structural pricing power that makes the current pullback an accumulation opportunity rather than a warning sign.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | $145.46 | bullish |
| 50 SMA | $146.52 | bullish |
| 200 SMA | $145.81 | bullish |
| RSI | 56.24 | neutral |
| MACD | -0.12 | bullish |
| MACD Signal | -0.46 | bullish |
| MACD Histogram | +0.34 | bullish |
| ATR | $2.68 | neutral |
| Bollinger Middle (20 SMA) | $145.09 | bullish |
| Bollinger Upper | $147.86 | neutral |
| Bollinger Lower | $142.32 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close above $152 on volume >10M shares
Then: Validates higher high above resistance; confirms MACD bullish crossover
EV: +5.4% · concedes: PG has underperformed the Nasdaq recently (expected for 0.377 beta defensive stock); FY27 faces ~8% core EPS headwind from input costs, financing expense, lower non-operating income, and FX; Trailing P/E of 22.3x and forward P/E of 19.95x are elevated metrics; PEG ratio of 3.74 suggests 'paying for stability, not growth'
PG is a yield substitute that doesn't yield enough—trading at 19.95x forward earnings with an 8% FY27 EPS headwind, a dividend yield 150bps below Treasuries, and a deteriorating quarterly earnings trajectory that makes the current multiple too rich.
· concedes: PG has a strong 70-year dividend streak and brand moat; The 30.29% ROE, while partly manufactured, reflects competent capital allocation; Low beta (0.38) means less downside in true selloffs; Tide innovation may defend market share against private label
→ vs conservative: The conservative analyst's income argument (2.98% yield vs 4.5% Treasury) is valid for pure income maximization but ignores PG's 70-year dividend-growth streak, 4.4% FCF yield, buyback optionality, and pricing power that bonds cannot offer
→ vs conservative: The 19.95x forward P/E and 3.74 PEG ratio are legitimate valuation concerns, but high returns on capital (30.29% ROE), strong margins, and stable debt justify a quality premium; a high PEG is dangerous for weak businesses, not for PG
→ vs conservative: Sequential Q1-to-Q4 EPS decline of 35% is seasonal, not structural; full-year FY26 EPS of $6.62 (up 12.2% from FY23) and Q4 FCF of $4.11B (up from $3.03B in Q3) contradict the broken earnings model narrative
→ vs neutral: The neutral analyst's concern about unconfirmed technical signals is reasonable for a full-size purchase at $147.64, but treating lack of confirmation as a reason to stay entirely in cash ignores that PG is forming higher lows, has constructive RSI of 56.24, and positive MACD momentum
→ vs neutral: The $140–$143 entry zone and $142 technical invalidation offer asymmetric risk/reward (8.6% to 17.7% upside vs approximately 3.8% downside), making waiting a high-conviction tactical decision rather than passivity
Support: 142.32 · 143 · 144 | Resistance: 147.86 · 148.01 · 148.86 · 150.38 · 151 · 152 · 153
PG is at a tactical inflection point following a recovery from the August 20 low of $142.97. The stock has reclaimed all three key moving averages (10 EMA, 50 SMA, and 200 SMA), indicating a short-term bullish regime shift. The August 27 MACD histogram crossover from -0.62 to +0.34 represents the first momentum buy signal since early August. Price action shows a textbook short-term uptrend with higher lows ($142.97 → $143.14 → $145.12 → $146.21 → $147.64). Near-term resistance sits at $147.86-$148.86, while critical support is $143-$144, with $142 as the invalidation level for the bullish setup. The final stance is HOLD—existing longs should be maintained with stops at $142, while new capital waits for either a pullback to $146-$146.50 or a breakout above $148.86 on volume greater than 10M shares.
Market Cap
$342.92 B
P/E (TTM)
22.30
Forward P/E
19.95
PEG Ratio
3.74
Price to Book
6.43
EPS (TTM)
$6.62
Forward EPS
$7.40
Dividend Yield
2.98%
Beta
0.377
52-Week High
$167.25
52-Week Low
$137.62
50-Day Average
$146.93
200-Day Average
$147.57
Gross Margin (TTM)
~50.9%
Operating Margin (TTM)
22.08%
Profit Margin (TTM)
18.44%
EBITDA (TTM)
$24.75 B
ROE
30.29%
ROA
10.72%
Revenue (FY2026)
$87.03 B
Net Income (FY2026)
$16.05 B
Diluted EPS (FY2026)
$6.62
Revenue CAGR (FY23-FY26)
~2.0%
Net Income CAGR (FY23-FY26)
~3.1%
Total Assets (Jun 2026)
$126.5 B
Stockholders' Equity
$54.08 B
Total Debt
$35.03 B
Net Debt
$24.20 B
Cash & Equivalents
$9.94 B
Debt/Equity
64.49%
Current Ratio
0.68
Operating Cash Flow (FY2026)
$19.56 B
Free Cash Flow (FY2026)
$15.15 B
CapEx (FY2026)
$4.41 B
Dividends Paid (FY2026)
$10.23 B
Buybacks (FY2026)
$5.03 B
Interest Coverage
~28x
Diluted Shares Outstanding
2.423 B
Strengths
Concerns
Procter & Gamble is a quality compounder with elite profitability metrics (ROE >30%, EBITDA $24.75B) and a fortress balance sheet characterized by stable debt (~35B), negative working capital (-$12.5B), and robust FCF ($15.15B). The company is a Dividend Aristocrat with 67+ consecutive years of dividend growth, returning substantial capital via dividends ($10.23B) and buybacks ($5.03B) in FY26. However, the stock trades at a premium (P/E 22.30x, PEG 3.74x) with limited growth (revenue CAGR ~2.0%), making it fully valued without a near-term catalyst for outperformance. The HOLD rating reflects a quality defensive name suitable for long-term allocation, but one that lacks compelling upside at current levels.
Macro: The macro backdrop is unusually friendly to high-quality defensives: prediction markets price an 89% probability of no Fed rate cuts in 2026, an 8% US recession probability (down 1.0 pp week-over-week), and 12% probability of inflation above 4.5%. Recession tail risk is pricing out (soft-landing/no-landing narrative), while sticky services inflation remains above the Fed's target. Rising bond yields driven by an energy shock create headwinds for long-duration multiples but support rotation into bond-proxy dividend aristocrats. The defensive rotation narrative—tech cooling off, aristocrats in favor—is actively being marketed across financial media.